Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
The stock's rise snapped a three-day losing streak.
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall ...
LOS ANGELES, CA / ACCESSWIRE / December 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...
Edwards Lifesciences (EW) Faces Investor Class Action Lawsuit Over TAVM Platform ...
EW Investors with Losses Encouraged to Contact the Firm Before Dec. 13, 2024 DeadlineSan Francisco, California--(Newsfile Corp. - December 10, ...
Edwards Lifesciences高管出售价值358,750美元的股票
根据 InvestingPro 指标显示，Edwards Lifesciences Corp (NYSE:EW)是一家财务状况良好的419亿美元市值的医疗设备公司。该公司企业战略和企业发展副总裁Donald E. Bobo Jr.最近出售了5,000股公司普通股。这些股票以71.7501美元的加权平均价格售出，交易总额为358,750美元。此次交易是根据预先制定的10b5-1交易计划执行的。
Edwards Lifesciences首席财务官Scott Ullem出售价值80.6万美元股票
根据 InvestingPro 分析，市值419亿美元且财务状况良好的医疗设备公司Edwards Lifesciences Corp (NYSE:EW)的首席财务官Scott B. Ullem最近进行了一系列股票交易，这些交易已向美国证券交易委员会备案。12月9日，Ullem以平均每股71.6805美元的价格出售了11,250股Edwards ...
Barchart on MSN1 天
Is Edwards Lifesciences Stock Underperforming the S&P 500?
Edwards Lifesciences Corporation (EW), a global leader in patient-focused medical innovations, was founded in 1958 and is ...
Edwards Lifesciences Corp. stock underperforms Monday when compared to competitors
This was the stock's third consecutive day of losses.
Edwards Lifesciences Co. (NYSE:EW) Shares Sold by HighTower Advisors LLC
HighTower Advisors LLC cut its holdings in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 0.8% in the 3rd ...
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s focused strategy for long-term sustainable growth, ...
Edwards Lifesciences (NYSE:EW) Price Target Raised to $90.00 at The Goldman Sachs Group
Edwards Lifesciences (NYSE:EW – Get Free Report) had its price target lifted by The Goldman Sachs Group from $81.00 to $90.00 ...
The Analyst Verdict: Edwards Lifesciences In The Eyes Of 17 Experts
Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $73.71, a high estimate of ...
Morningstar2 天
Edwards Lifesciences Corp EW
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...